Literature DB >> 5937610

Alpha-hydroxybutyrate dehydrogenase activity in sex-linked muscular dystrophy.

H A Johnston, J H Wilkinson, W A Withycombe, S Raymond.   

Abstract

In two families with severe sex-linked muscular dystrophy, high levels of alpha-hydroxybutyrate dehydrogenase (HBD), lactate dehydrogenase (LD), aspartate transaminase (AspT), aldolase, and creatine phosphokinase (CPK) were found in the sera of three young affected males. In both families the mother had a raised level of HBD activity. Four sisters of the three affected boys had raised serum enzyme levels, and they are regarded as presumptive carriers of the disease. Biopsy specimens of dystrophic muscle had LD and HBD contents which were significantly lower than those of control specimens, while the HBD/LD ratios were markedly greater. Muscle from two unaffected members of the same family also exhibited high ratios, indicating the presence of the electrophoretically fast LD isoenzymes, and this was confirmed by acrylamide-gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5937610      PMCID: PMC473248          DOI: 10.1136/jcp.19.3.250

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  28 in total

1.  ELECTROPHORETIC DISTRIBUTION PATTERN OF LACTATE DEHYDROGENASE IN MOUSE AND HUMAN MUSCULAR DYSTROPHY.

Authors:  M G LAURYSSENS; M J LAURYSSENS
Journal:  Clin Chim Acta       Date:  1964-03       Impact factor: 3.786

2.  SERUM ALPHA-HYDROXYBUTYRATE DEHYDROGENASE: A NEW TEST FOR MYOCARDIAL INFARCTION.

Authors:  S B ROSALKI
Journal:  Br Heart J       Date:  1963-11

3.  THE SIGNIFICANCE OF LACTATE DEHYDROGENASE ISOZYMES IN ABNORMAL HUMAN SKELETAL MUSCLE.

Authors:  I A BRODY
Journal:  Neurology       Date:  1964-12       Impact factor: 9.910

4.  [Enzyme activity determinations in healthy human musculature and in myopathies. II. Enzyme activity changes in muscle in progressive muscular dystrophy].

Authors:  H HEYCK; G LAUDAHN; C J LUDERS
Journal:  Klin Wochenschr       Date:  1963-05-15

5.  [Muscle lactic dehydrogenase in myopathy: apparent persistence of the fetal type].

Authors:  J C DREYFUS; J DEMOS; F SCHAPIRA; G SCHAPIRA
Journal:  C R Hebd Seances Acad Sci       Date:  1962-06-18

6.  Serum "alpha-hydroxybutyric dehydrogenase" in myocardial infarction and in liver disease.

Authors:  B A ELLIOTT; J H WILKINSON
Journal:  Lancet       Date:  1961-04-01       Impact factor: 79.321

7.  [Progressive muscular dystrophy. I. The heterogenicity of serum lactic dehydrgenase].

Authors:  R RICHTERICH; E GAUTIER; W EGLI; K ZUPPINGER; E ROSSI
Journal:  Klin Wochenschr       Date:  1961-04-01

8.  An investigation of the carrier state in the Duchenne type muscular dystrophy.

Authors:  P LEYBURN; W H THOMSON; J N WALTON
Journal:  Ann Hum Genet       Date:  1961-05       Impact factor: 1.670

9.  Serum aldolase in muscle disease.

Authors:  R A THOMPSON; P J VIGNOS
Journal:  AMA Arch Intern Med       Date:  1959-04
View more
  5 in total

1.  Diagnostic accuracy of serum enzyme assays for myocardial infarction in a general hospital population.

Authors:  D M Goldberg; D A Winfield
Journal:  Br Heart J       Date:  1972-06

2.  Application of new ultra-micro automated spectrophotometric determination for serum hydroxybutyrate dehydrogenase activity to diagnosis of myocardial infarction.

Authors:  A D Hirst; D M Goldberg
Journal:  Br Heart J       Date:  1970-01

3.  The determination of lactate dehydrogenase isoenzymes in normal human muscle and other tissues.

Authors:  A E Emery
Journal:  Biochem J       Date:  1967-11       Impact factor: 3.857

4.  Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.

Authors:  R C Hughes; D C Park; M E Parsons; M D O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-10       Impact factor: 10.154

5.  Quantitative EMG and histological carrier detection of Duchenne muscular dystrophy.

Authors:  G Scarlato; G Valli; G Meola; L Carenini
Journal:  J Neurol       Date:  1977-11-01       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.